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SUBJECT	 Study Report
A Prioritized Set of Physiological Measurements
L	 for Future Spaceflight Experiments
This report identifies a set of desired experimental measurements to be
obtained in future spaceflights in four areas of physiological investi-
gation. The basis for identifying the measurements was the physiological
systems analysis performed on Skylab data and related ground-based studies.
An approach for prioritizing the measurement list is identified and dis-
cussed with the use of examples.
Finally, a prioritized measurement list is presented for each of the
follow i ng areas: Cardiopulmonary, Fluid-Renal- and Electrolyte, Hema-
tology end Immunology, and MuscvlW o letal. Also included is a list of
interacting stresses and other factors p resent in spaceflight experiments
whose effects may need to be quantified.
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4
The list of measurements described in this report is intended to
identify, in the view of the author, both the measurements which should be
made in the upcoming Shuttle Human Spaceflight experiments and the relative
importance of each measurement expressed as a category or priority.
The basis for selecting these measurements is the knowledge and
experience gained in the integrated analysis and interpretation of Skylab
data and related gro-ind-based studies.
The assignment of priorities to physiological measurements on this
list, even within a discipline subdivision, requires clear identification
of the program objectives. These program objectives could include-
1. Further the basic understanding of the mechanisms involved
in physiological adaptation to the spaceflight environment.
2. Development of specific countermeasures to reduce objectionable
physiological effects of spaceflight (with frequent short term flights and
extended duration missions).
3. To provide a basis of health care monitoring in space. This
includes predictive capability for normal physiological changes for a
relatively diverse population of ?xposed persons and interactions with
additional environmental streises, metabolic stresses, or disease states.
Although these program objectives have not been completely defined,
as yet, it is apparent that both the second and third objectives listed
are somewhat de pendent on the first objective listed. Therefore the approach
taken to prioritizing the measurements was to consider only the contribution
to an enhanced understanding of Spaceflight induced physiological changes.
This ap p roach will hopefull y reflect the a pp raised value of the measurement
to testin q current hypotheses.
Orqanization
Physiological research during the Shuttle Program will be organized
into investigative areas according to the major physiological systems
Zinvolved. The investigative areas and the major spaceflight effects con-
sidered are given in Table 1. The same subsystem breakdown will be used 	
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in the development of this list.
The priority assigned to a particular measurement will, insofar as
Possible, be a function of its role in an integrated hypothesis which
describes the total process of adaptation. The more central the effect,
the more value assigned to it. As an example, the headward migration of
blood from the legs into the thoracic cavity is an acute effect of zero-g
exposure that has short term and long term consequences in the cardiovas-
cular, fluid electrolyte control and hematological systems and suspected
intera-:tions with the pulmonary, musculoskeletal, and other physiological
subsystems. Therefore, temporal characterization of the volume shifts, and
associated pressures and flows will have considerable value as a primary
stimulus for producing a wide range of the observed effects of spaceflight.
From these considerations, a set of categories can be defined to
prioritize the suggested measurements in each investigative area. The cate-
gories are defined in Table II. As can be seen in the list, these categories
do not necessarily dictate the overall priority of the measu rement since the
overriding considerations may be of a more subjective nature. The categories
do, however, remain a descriptor of the perceived application of the measure-
ment.
Modifying Factors
Once program objectives are defined in detail, the priorities for
the suggested measurements could be modified accordingly. The development
of countermeasures as a program objective would require identifying the
most likely adaptive mechanisms involved, the degree of counteracting stimu-
lus required, and the most effective means of providing the stimulus for the
least resources (time, weight, power, dollar, subjective discomfort). For
example, the rational development of exercise countermeasures would require
differentiating the contributions of hypovolemia, decreased function of ex-
ercising, muscle fatigue, any: additional spaceflight-induced biochemical
changes on postflight exercise capacity. The ability to counteract the
induced changes would be assessed, in this case by providing rapid rehydra-
tion or infusion of plasma, constituents, maintaining muscle function w'th
3TABLE I
MAJOR EFFECTS OF SPACEFLIGHT OBSERVED TO DATE
Fluid, Electrolyte,e, and Hormonal
0	 Decrease in weight inflight
0	 Decrease in TBW (pre-post)
0	 Decrease in plasma volume (pre-post)
0	 Decrease in total body sodium (pre-post)
0	 Decrease in total body potassium (pre-post)
0	 No measured Henry-Gauer diuresis
0	 Increase in aldosterone excretion
0	 Decrease leg volume
0	 Increased upper body volume including puffy faces, nasal congestion
0	 Decreased plasma osmolality
0	 Increased cortisol excretion
0	 Decreased excretion of epinephrine and norepinephrine
Cardiovascular
o	 Decreased orthostatic tolerance (inflight, LBNP, postflight)
o	 Decreased exercise capacity (postflight)
o	 Decreased exercisitg cardiac output (postflight)
o	 Decreased effective circulating blood volutre (postflight)
o	 Increased heart rate inflight
Musculoskeletal
0	 Decrease its	 bone mineral	 content	 (os	 calcis)
o	 Negative balance of calcium, phosphorus, and
o	 Muscular imbalance occasioned by functional
gravity muscles
o	 Decrease in	 lean body mass
o	 Negative energy balance first week	 inflight
related to mission duration
introgen inflight
disuse atrophy of anti-
Hematol9_2y and Immunology
0	 Decreased red cell mass not related to mission duration
o	 No evidence for increased destruction
o	 Apparent suppression of red cell production
o	 Decreased immunological function during and postflight
0	 Increased inflight hemaglobin concentration.
4TABLE II
DEFINITION OF CATEGORIES
Category 1 - Critical to verify existing hypotheses involving more than
one major effect of spaceflight (Table I).
Category 2 - Critical to a specific hypothesis involving a single major
effect of spaceflight.
Category 3 - Confirmatory, amplifying or sipporting, measurements related
to one or more existing hypotheses.
Category 4 - Desirable to confirm or explain minor (not in Table I and
not in mainstream of adaptive process) effects of spaceflight.
Category 5 - Desired to investigate suspected additional spaceflight
effects.
specific inflight exercises, assuring adequate rest before the landing. The
quantitative aspects of the therapy would be based on the amount of fluids
lost in the first case and perhapi. the amount of rest required in the last
case. The therapeutic use of infli ght exercise, however, would have at
least the following parameters: 1) preflight level of subject condition-
ing to perform the exercise (aerobic ca pacit;, perhaps), 2) muscle groups
involved, 3) type of exercise indicated (viz, isokinetic, isotonic, iso-
metric), 4) intensity and duration (may be a function of all the above
factors). As can be readily seen, the number of potential experiments
which could be performed to optimize countermeasures for maintaining exer-
cise capacity is conceivably very large. As a program objective, this
would require assignment of priorities to the measurements which will assess
the functions and optimize the parameters discussed hove.
An additional consideration in designing countermeasures and one
which may he of particular concern in the development of physiological
baselines for monitoring crew health (program objective #3) will be the
sources of individual variation. The population of persons who will fly in
the Shuttle program is much more diverse than the astronauts population of
the previous programs in terms of age, sex, physical conditioning, and
many other parameters affecting health status. These factors present an
additional dimension in the requirements for experimental data collection.
The priority for an exper;ment to quantitate these factors can be deter-
mined only by a clear program objective and possibly screening by using
appropriate ground-based analogs.
Limitations
Tne greatest single limitation imposed upon this measurement list is the
assumption that the onl y objective is ore of advanrinn nur hasir nnriarttandinn
of the adaptive process. A great many other factors in the selection of
experiments have been ignored. Some of the factors which affect the scien-
tific desirability of investigations or which will play a role in the selec-
tion, of experiments include:
1. Directness of measurement techniques
2. Experiment controls
6.r
Cateyor^r
(1)
(1)
(4)
FLUID, ELECTROLYTE, RENAL
Desired Timinnc, days after launch
Measurement
	
0-1	 1-5
	 >5	 Recov.
Central	 Venous Pressure X X X X
Thoracic Blood Volume X X X X
Leg Volume,	 total X X X
Vascular X Y, X
Extravascular X X X
Diuresis	 (well	 hydrated) X
Plasma ADH X X X X
h 2 0	 Intake X X
Free Water Clearance X X X X
Renal	 Plasma Flow X X X
GFR X X X X
Natriuretic Factor X X X, X
Aldosterone Secretion
Evaporative Water Loss
K+ - Nitrogen Relation
pH Plasma, Urinary
Na + /Ca
4+
 Urinary Factors
Intracellular Na + , K+ , H+
Cortisol Effects on K + Excretion
Total Body Water
(2)
(2)
(3)
(3)
(3)
(2)
(2)
(4)
(3,4)
(3,4)
(4)
(3,4)
(4)
(4)
X	 X X	 X
X	 X X	 X
X	 X X	 X
X	 X X	 X
X X	 X
X	 X X	 X
X	 X X	 X
X X	 X
73. Concomitant measurements with interpretive value
4. Probability of obtaining statistical significant results
5. Interference between experiments
The proposed list also ignores engineering and operational feasibility and
resource requirements.
Much has been said and could be said about each element of the list
presented, however, it should be pointed out that some desired measure-
ments could be implied or inferred from other measurements, either with
the addition of assumptions or a formal mathematical model of the physio-
logical system. For exam p le, in the acute phase of adaptation following
launch, plasma volumes may be inferred from hematocrit data by assuming
red cell volume does not change during this interval.
A	 ,
Category
(1)
(1)
(1)
(1)
(3 1
(1)
(1)
(1)
(2)
(3,4)
0)
(5)
(2)
(5)
(3)
(3)
(4)
(4)
(1)
(3,4)
(5)
(5)
(3,4)
CARDIOPULMONARY
Measurement
	 Desired Timing days after launch
0-1 hr	 1-5 da ys %5 da y s	 Post
Central	 Blood Pressure X X X
Total	 Blood Volume X X X X
Total	 Leg Volume X X X X
Leg Blood Volume X X X
Leg Blood Flow X X X X
Thoracic Blood	 Volume X X X
Renal	 Blood Flow X X X
Cardiac Output X X X X
TPR X X X
SV X X X
High Pressure Baroreceptor
Activity X X
Venous Compliance X X X
Circadian	 Variability Plasma	 Vol. X X X
Blood Gas and pli X X X X
P50 Shifts on Oxyhemoglobin Sat. X
Pre/Post Capillary Resistance	 in
Various Tissue X X
Plasma Proteins
	
Conc. X X X X
Humoral	 Control	 Factors
Circulating	 catec.holamines, X X X
renin/angio X X X
Vital	 Capacity X X X X
Exercising RER X X X X
24-hour Metabolic	 Rate X
Basal	 Metabolic Rate X X
Direct Cardiac
	
Function X X
Ventilation/Perfusion Ratio X X X
MAX 02
 Uptake X X X
9MUSCULCSKELETAL
Category. Mea.,urement Desired Timing, days after launch
0 -1 1 -5 days >5 Recov.
(1) Skeletal	 Ca	 Losses X
(1) Distribution of Bone Mineral X
Loss
(3) Ca++
	
plasma,	 urine X X X X
(3) Urinary Hydroxyproli„e X X X X
(2) Calcitonin X X X X
(2) Vitamin D 3	(metabolites) X X X X
(2) PTH plasma X X X X
(3) PO4 Excretion X X X X
(1) Loss	 in Muscle Mass X
(1) Distribution of Muscle Mass
Losses X
(3,4) Type of Muscle Fiber Lost X
(3) Energy Balance X X X
(1) 24-hr.	 Energy Utilization X X X X
(3,5) BMR,	 Thyroxine X X X
(3) Nitrogen-K+ Excretion X X X X
(2) Defoniiation Forces	 in bone X X X
(5) GIT Transit Time X X X
(4) Absorption of Fat Soluble
Vitamins X X X
OTHER FACTORS OF INTEREST
Space Motion Sickness
Therapeutic Drug/Spaceflight Interaction
Acceleration ( +gz)
Circacian Shifts (work/rest, sleep cycles)
Ionizing Radiation
Psychological Indices
Toxicity Monitoring
Thermal Anomalies
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HEMATOLOGY b IMMUNOLOGY
CLslo—"y
	
Measurement
	
Desired Timinq. days _after launch
0-1	 1-5	 >5	 Recov.
(2) Erythropoietin x	 X	 x	 x
(2) Hematocrit x	 x	 x
(2) Hemoglobin vs.	 RCM x	 x	 x
(1,3) Renal	 Blood Flow x	 x	 x
(4) p50 Shift x	 x
(3) RBC Life Span x
(3) Iron Uptake x	 x	 x
(5) Biliruben x	 x
(4) Species Differences	 in
Experimental	 Animal
Models
(1) Mechanism of	 Inununusup-
pression
